Although use of dietary supplements is not always recommended, it is best for clinicians to be knowledgeable about the safety and efficacy data surrounding them in order to assist patients who choose to use them.
To shed light on the often-challenging management of this common condition, MPR presented the case of a hypothetical patient to a doctor who specializes in advanced heart failure and transplant cardiology.
Drugs with pharmacogenetic associations related to drug metabolizing enzyme gene variants, drug transporter gene variants, and gene variants that have been related to a predisposition for certain adverse events.
A drug commonly used to treat hyperkalemia has the potential to damage the GI mucosa, especially in surgical patients or patients with end-stage renal disease.
Physician assistants managing the care of patients with systemic lupus erythematosus must consider both the traditional and SLE-specific risk factors for cardiovascular disease.
Familial hypercholesterolemia (FH), an inherited genetic disorder characterized by significantly elevated low-density lipoprotein cholesterol (LDL-C) levels, affects an estimated 620,000 Americans and is generally underdiagnosed and undertreated.
